- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1374
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1374 companies
Kidswell Bio
Market Cap: JP¥13.2b
Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.
4584
JP¥278.00
7D
1.5%
1Y
120.6%
Champions Oncology
Market Cap: US$88.1m
A technology-enabled research company, provides technology solutions for drug discovery and development in the United States.
CSBR
US$6.30
7D
-4.0%
1Y
33.5%
2invest
Market Cap: €75.0m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.
2INV
€13.60
7D
3.8%
1Y
29.5%
Quince Therapeutics
Market Cap: US$87.6m
A biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.
QNCX
US$1.61
7D
0.6%
1Y
101.3%
aTyr Pharma
Market Cap: US$87.5m
A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
ATYR
US$0.84
7D
-15.3%
1Y
-52.5%
InflaRx
Market Cap: US$87.4m
A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.
IFRX
US$1.30
7D
-3.0%
1Y
-17.2%
Metagenomi
Market Cap: US$86.3m
A genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States.
MGX
US$2.29
7D
11.7%
1Y
3.2%
Satellos Bioscience
Market Cap: CA$118.9m
A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.
MSCL
CA$0.66
7D
4.8%
1Y
40.4%
Assertio Holdings
Market Cap: US$85.2m
A pharmaceutical company, provides various products to patients in the United States.
ASRT
US$0.89
7D
-2.1%
1Y
-25.0%
BioStem Technologies
Market Cap: US$85.0m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$4.97
7D
-3.8%
1Y
-50.3%
Hyphens Pharma International
Market Cap: S$109.6m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.35
7D
-5.3%
1Y
22.4%
OKYO Pharma
Market Cap: US$83.5m
A clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.
OKYO
US$2.18
7D
10.1%
1Y
114.8%
Bangkok Lab And Cosmetic
Market Cap: ฿2.7b
Manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Myanmar, and internationally.
BLC
฿4.48
7D
-3.4%
1Y
-20.7%
Equillium
Market Cap: US$83.3m
A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.
EQ
US$1.50
7D
2.7%
1Y
80.2%
Vaxart
Market Cap: US$82.2m
A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.
VXRT
US$0.37
7D
-4.4%
1Y
-55.0%
XBiotech
Market Cap: US$82.0m
A biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases.
XBIT
US$2.70
7D
-0.7%
1Y
-62.6%
HLB bioStepLtd
Market Cap: ₩114.5b
Provides various test services.
A278650
₩1,355.00
7D
-1.5%
1Y
-42.8%
Context Therapeutics
Market Cap: US$81.0m
A biopharmaceutical company, develops products for the treatment of solid tumors.
CNTX
US$0.91
7D
-6.0%
1Y
-51.1%
Domesco Medical Import - Export
Market Cap: ₫2.1t
Engages in the research and development, manufacturing, marketing, and trading of pharmaceutical products, herbal-origin medicines, functional foods, purified drinking water, and herbal-based beverages in Vietnam.
DMC
₫60,600.00
7D
-0.7%
1Y
-10.9%
IBN SINA Pharmaceutical Industry
Market Cap: ৳9.7b
Produces and sells pharmaceutical drugs in Bangladesh and internationally.
IBNSINA
৳310.70
7D
-1.6%
1Y
-14.4%
Bayer (Peru)
Market Cap: S/294.5m
Engages in the pharmaceuticals, consumer health, and crop science businesses in Peru.
BAYERI1
S/20.00
7D
0%
1Y
41.8%
Sol-Gel Technologies
Market Cap: US$78.0m
Together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally.
SLGL
US$28.99
7D
-5.0%
1Y
326.4%
LTR Pharma
Market Cap: AU$119.4m
A clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.
LTP
AU$0.66
7D
-10.2%
1Y
-61.8%
KoBioLabs
Market Cap: ₩109.3b
Provides microbiome therapeutics for metabolic, immune, and neurological diseases.
A348150
₩5,630.00
7D
-8.2%
1Y
-14.7%
Merck
Market Cap: Rp1.3t
Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.
MERK
Rp2,860.00
7D
2.1%
1Y
-23.9%
CellSource
Market Cap: JP¥11.5b
Engages in the regenerative medicine-related businesses in Japan.
4880
JP¥579.00
7D
0%
1Y
-55.6%
X4 Pharmaceuticals
Market Cap: US$75.9m
A biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.
XFOR
US$3.46
7D
9.1%
1Y
-82.4%
PMV Pharmaceuticals
Market Cap: US$74.2m
A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.
PMVP
US$1.48
7D
13.0%
1Y
-1.3%
Hofseth BioCare
Market Cap: NOK 735.8m
Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States.
HBC
NOK 1.79
7D
-4.0%
1Y
8.5%
Artiva Biotherapeutics
Market Cap: US$73.5m
A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.
ARTV
US$2.96
7D
2.8%
1Y
-78.9%
Sutro Biopharma
Market Cap: US$73.4m
Operates as a oncology company.
STRO
US$0.89
7D
0%
1Y
-74.7%
Zhongzhi Pharmaceutical Holdings
Market Cap: HK$570.0m
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
3737
HK$0.66
7D
-4.3%
1Y
-32.7%
Trajan Group Holdings
Market Cap: AU$112.1m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.73
7D
-2.3%
1Y
-41.0%
Sam-A Pharm
Market Cap: ₩102.7b
Operates as a pharmaceutical company in South Korea.
A009300
₩16,820.00
7D
-2.5%
1Y
-21.2%
MaaT Pharma
Market Cap: €61.8m
A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.
MAAT
€3.84
7D
-3.0%
1Y
-48.2%
Jerusalem Pharmaceuticals
Market Cap: US$72.0m
Develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.
JPH
US$4.00
7D
0.3%
1Y
11.1%